A re-staging transurethral resection predicts early progression of superficial bladder cancer. Academic Article uri icon

Overview

abstract

  • OBJECTIVE: To determine whether pathology on a re-staging transurethral resection (TUR) predicts the early progression of superficial bladder cancer. PATIENTS AND METHODS: In all, 710 patients presenting with multiple superficial bladder cancers were evaluated by re-staging TUR and followed for 5 years. Tumours were classified by stage as confined to mucosa (Ta) or invading submucosa (T1), and by grade (low- or high-grade). Pathology on re-staging TUR was correlated with the endpoints of tumour recurrence and stage progression. RESULTS: Of the 710 patients, 490 (69%) had a recurrence and 149 (21%) progressed over 5 years. Eighty patients had high-grade invasive (T1G3) cancer on re-staging TUR and 61 (76%) progressed to muscle invasion (median time to progression 15 months), compared with 88 of 630 (14%) who had no evidence of tumour (T0) or other than T1 tumours detected on re-staging TUR. CONCLUSION: A re-staging TUR identifies patients with superficial bladder cancer who are at high risk of early tumour progression.

publication date

  • March 23, 2006

Research

keywords

  • Cystectomy
  • Neoplasm Recurrence, Local
  • Urinary Bladder Neoplasms

Identity

Scopus Document Identifier

  • 33745216241

Digital Object Identifier (DOI)

  • 10.1111/j.1464-410X.2006.06145.x

PubMed ID

  • 16566813

Additional Document Info

volume

  • 97

issue

  • 6